Cell growth pathways are mediated through protein-glycan interactions including O-glycosylation. Investigation of these growth pathways can be carried out using appropriate inhibitors to identify stagespecific events. We have adopted this approach to study a group of benzyl-O-N-acetyl-d-galactosamine analogues in human colorectal cancer cell lines. Exposure to O-glycan inhibitors resulted in the induction of apoptosis, a block in proliferation, accumulation of intracellular aryl-glycans and changes in related genes as detected by gene array. Colorectal cancer cell lines susceptible to the inhibitors showed growth arrest with all compounds. However, a differential action of each inhibitor was detected in the pattern of genes affected and in the structure of aryl-glycans formed.
Introduction
The growth of cells is mediated through a wide variety of pathways that have considerable cross-talk and are adapted to specific tissue locations in mammals. In particular, regulation of apoptosis and proliferation have been identified as major events in cell growth control [1] . The Wnt and Notch pathways regulate these events in epithelial cells through signalling cascades of proteins acting both at the cell surface and intracellularly [1] . Many proteins in these pathways are subject to post-translational modifications. Glycosylation is a major post-translational event where glycan chains are linked at specific peptide backbone locations [2] . However, the uncertainty in predicting the relationship of protein glycosylation to function has resulted in the need to evaluate the relevance of glycosylation for each protein in its functional environment. Therefore it is necessary to identify the structural nature and extent of glycosylation in target proteins and to investigate the consequences of blocking or modifying glycosylation in a defined test system [3] [4] [5] .
O-glycosylation and the function of glycoproteins
Protein glycosylation is widespread and has many functional consequences for the metabolism of the proteins that carry them. Although different functions of glycosylation have been identified [3] [4] [5] and important biological structurefunction relationships have been characterized, it has not Key words: apoptosis, benzyl-O-N-acetyl-d-galactosamine, colorectal cancer, O-glycosylation, mucin, signal pathway.
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been possible to ascribe a function simply on the basis of glycosylation. The major glycosylation pathways include the O-glycans; oligosaccharides linked through N-acetyl-Dglucosamine to asparagine giving rise to the family of Nlinked glycans and the glycosylphosphatidylinositol anchors [2] . The O-glycans include the mucin-type oligosaccharides with N-acetyl-D-galactosamine linked to serine and threonine. Pathways for the biosynthesis of the mucin-type O-glycans have been well studied at both enzymatic and structural levels [6, 7] .
The functions of O-glycans in proteins are varied. Knowledge of the substitution and structure of O-glycans on individual proteins is a prerequisite for a complete analysis of their function. Functions of O-glycans in proteins can be linked to protein conformation and stability. This is relevant to protein folding at the tertiary structural level and is well documented for the mucin glycoproteins (mucins) with high O-glycosylation. Other glycoproteins show clustering of O-glycans to create extended 'stalk' peptide domains, enabling the orientation of functional/binding domains away from the cell-surface membrane. Interactions at the quaternary level have also been shown to depend on the conformation mediated by protein O-glycosylation. Oglycans can also protect against both proteolytic digestion and thermal degradation [7] . A further functional role of O-glycans depends on the opportunity to present clusters of glycan ligands within proteins. Multivalent and multimeric ligand presentation plays a role in the amplification of signals through ligand-receptor interactions. The strength of binding is also increased through this mechanism and a combination of these phenomena increases the sensitivity of recognition.
Recognition phenomena mediated by O-glycans are well known. Cell proliferation and growth is detailed in the 
Regulation of cell growth through glycosylation of signalling pathway proteins
Recognition of glycan structures in cell-surface membrane proteins which play a role in the control of apoptosis and proliferation has been reported [9] . Oncogenes which respond to changes in glycosylation include H-and NRas, Src, HER2/neu and the p16 INK4a tumour suppressor [10] . β1 integrins are important ligands for cell growth, and their glycosylation is dictated by the Ras-Raf-MEK-ERK (where ERK is extracellular-signal-regulated kinase and MEK is mitogen-activated protein kinase/ERK kinase) pathway [11] . Control of apoptosis through selective glycosylation has been shown for the binding of galectin-1 to its endogenous ligand CD45 on immature thymocytes and activated T-cells [12, 13] . These observations sustain the notion of a role for glycan recognition in cell growth regulation through their appearance on pathway-specific glycoproteins.
Action of O-glycan inhibitors in colorectal cancer cell lines
The use of glycosylation inhibitors is a valuable tool to probe the significance of glycosylation. We have synthesized a series of compounds based on the aryl-glycoside, benzyl-OGalNAc (benzyl-O-N-acetyl-D-galactosamine; Figure 1 ), reported previously [14] . Growth arrest occurred on exposure of cells to benzyl-O-GalNAc as well as all of the analogues synthesized [14] . The inhibitors act at both intermediary metabolic and genomic levels. Benzyl-O-GalNAc is known to be a competitive inhibitor of O-glycosylation, leading to the formation of benzyl-oligosaccharides which accumulate within susceptible cells [15] . The structure of the arylglycans formed with each analogue of benzyl-O-GalNAc has been identified and reflects the mode of action of the inhibitor and the repertoire of glycosyltranferases within the cell line under study [15] . Gene array using the Affymetrix Human Genechip U133A 2.0 showed the involvement of genes relating to proliferation, apoptosis and glycobiology and matches the cellular behaviour and aryl-glycan products leading to growth arrest.
Conclusion: O-glycosylation mediates colorectal cell growth
This work demonstrates that the use of O-glycosylation inhibitors is a valuable technique to investigate cell growth. O-glycosylation is closely involved in the regulation of cell growth in colorectal cancer cells as well as being mediated at the intermediate metabolic and genomic levels.
